Atlas Venture Associates IX, LLC - SPERO THERAPEUTICS INC ownership

SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 61 filers reported holding SPERO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Atlas Venture Associates IX, LLC ownership history of SPERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,637,497
-16.6%
1,353,3030.0%13.93%
+29.7%
Q2 2023$1,962,289
-1.7%
1,353,303
-1.7%
10.74%
+14.6%
Q1 2023$1,996,604
-16.2%
1,376,9680.0%9.37%
-20.9%
Q4 2022$2,382,155
-13.5%
1,376,9680.0%11.85%
+45.2%
Q3 2022$2,754,000
+170.3%
1,376,9680.0%8.16%
+252.6%
Q2 2022$1,019,000
-91.5%
1,376,9680.0%2.32%
-79.0%
Q1 2022$11,980,000
-45.7%
1,376,9680.0%11.02%
+14.5%
Q4 2021$22,045,000
-13.0%
1,376,9680.0%9.62%
+14.2%
Q3 2021$25,350,000
+31.9%
1,376,9680.0%8.43%
+149.1%
Q2 2021$19,223,000
-5.2%
1,376,9680.0%3.38%
-0.7%
Q1 2021$20,269,000
-24.1%
1,376,9680.0%3.40%
-19.5%
Q4 2020$26,700,000
+73.7%
1,376,9680.0%4.23%
-73.4%
Q3 2020$15,367,000
-17.5%
1,376,9680.0%15.90%
-20.2%
Q2 2020$18,631,000
+67.5%
1,376,9680.0%19.92%
-15.3%
Q1 2020$11,126,000
-16.0%
1,376,9680.0%23.53%
+1.9%
Q4 2019$13,247,000
-9.2%
1,376,9680.0%23.08%
-3.9%
Q3 2019$14,596,000
-7.9%
1,376,9680.0%24.02%
+41.7%
Q2 2019$15,849,000
-10.1%
1,376,9680.0%16.95%
+2.3%
Q1 2019$17,639,000
+108.3%
1,376,9680.0%16.57%
+69.9%
Q4 2018$8,468,000
-41.5%
1,376,9680.0%9.75%
+27.3%
Q3 2018$14,472,000
-28.4%
1,376,9680.0%7.66%
-13.9%
Q2 2018$20,200,000
+2.9%
1,376,9680.0%8.89%
-40.1%
Q1 2018$19,622,000
+21.3%
1,376,9680.0%14.83%
+3.5%
Q4 2017$16,179,0001,376,96814.33%
Other shareholders
SPERO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 3,932,209$76,246,00015.85%
Atlas Venture Associates XI, LLC 1,376,968$26,700,0004.23%
Atlas Venture Associates IX, LLC 1,376,968$26,700,0004.23%
BVF INC/IL 2,243,278$43,497,0001.71%
AWM Investment Company, Inc. 372,755$7,228,0000.92%
Alphabet Inc. 889,979$17,257,0000.83%
Rock Springs Capital Management LP 1,235,000$23,947,0000.51%
Novo Holdings A/S 576,702$11,182,0000.48%
Artal Group S.A. 500,000$9,695,0000.21%
Granahan Investment Management 420,320$8,150,0000.18%
View complete list of SPERO THERAPEUTICS INC shareholders